| Andrea M Harangozo, MD | |
|
593 Cranbury Road, Suite 1a, East Brunswick, NJ 08816 | |
| (732) 613-8880 | |
| (732) 613-0077 |
| Full Name | Andrea M Harangozo |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 40 Years |
| Location | 593 Cranbury Road, East Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982793253 | NPI | - | NPPES |
| 933679 | Other | NJ | AETNA US HC |
| P2163446 | Other | NJ | OXFORD |
| 0973203 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Robert Wood Johnson University Hospital | New brunswick, NJ | Hospital |
| Saint Peter's University Hospital | New brunswick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Robert Wood Johnson Physician Enterprise | 5597917633 | 47 |
| Pulmonary And Intensive Care Specialists Of New Jersey | 6204725617 | 7 |
News Archive
Researchers from Northwestern University and the University of Rochester in the U.S. addressed this question in their study. The researchers also explored whether the vaccines administered across the world could confer sterilizing immunity while preventing severe disease and death.
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Now, a team of researchers at the Massachusetts Institute of Technology (MIT) has found that asymptomatic people may differ from those who are healthy in the way they cough. The differences are inaudible to the human ear but can be detected by artificial intelligence (AI).
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Australian Medical Association President, Dr Bill Glasson, said today that Kraft Asia Pacific has missed a golden opportunity to show leadership in the battle against the epidemic of childhood obesity by not following its US counterpart and modifying advertising of its products to children under the age of 12.
› Verified 9 days ago
| Entity Name | Pulmonary And Intensive Care Specialists Of New Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366531634 PECOS PAC ID: 6204725617 Enrollment ID: O20040313000106 |
News Archive
Researchers from Northwestern University and the University of Rochester in the U.S. addressed this question in their study. The researchers also explored whether the vaccines administered across the world could confer sterilizing immunity while preventing severe disease and death.
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Now, a team of researchers at the Massachusetts Institute of Technology (MIT) has found that asymptomatic people may differ from those who are healthy in the way they cough. The differences are inaudible to the human ear but can be detected by artificial intelligence (AI).
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Australian Medical Association President, Dr Bill Glasson, said today that Kraft Asia Pacific has missed a golden opportunity to show leadership in the battle against the epidemic of childhood obesity by not following its US counterpart and modifying advertising of its products to children under the age of 12.
› Verified 9 days ago
| Entity Name | Robert Wood Johnson Physician Enterprise |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245587922 PECOS PAC ID: 5597917633 Enrollment ID: O20121218000345 |
News Archive
Researchers from Northwestern University and the University of Rochester in the U.S. addressed this question in their study. The researchers also explored whether the vaccines administered across the world could confer sterilizing immunity while preventing severe disease and death.
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Now, a team of researchers at the Massachusetts Institute of Technology (MIT) has found that asymptomatic people may differ from those who are healthy in the way they cough. The differences are inaudible to the human ear but can be detected by artificial intelligence (AI).
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Australian Medical Association President, Dr Bill Glasson, said today that Kraft Asia Pacific has missed a golden opportunity to show leadership in the battle against the epidemic of childhood obesity by not following its US counterpart and modifying advertising of its products to children under the age of 12.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea M Harangozo, MD 593 Cranbury Road, Suite 1a, East Brunswick, NJ 08816 Ph: (732) 613-8880 | Andrea M Harangozo, MD 593 Cranbury Road, Suite 1a, East Brunswick, NJ 08816 Ph: (732) 613-8880 |
News Archive
Researchers from Northwestern University and the University of Rochester in the U.S. addressed this question in their study. The researchers also explored whether the vaccines administered across the world could confer sterilizing immunity while preventing severe disease and death.
SeptRx, an emerging medical device company that has developed the SeptRx Intrapocket PFO Occluder (IPO), reported today that it has completed enrollment for its "InterSEPT" (In-tunnel SeptRx European PFO Trial) clinical trial in Europe, and has entered into a partnership with CoRRect Medical GmbH for commercial distribution in Germany and Switzerland of the SeptRx IPO.
Now, a team of researchers at the Massachusetts Institute of Technology (MIT) has found that asymptomatic people may differ from those who are healthy in the way they cough. The differences are inaudible to the human ear but can be detected by artificial intelligence (AI).
Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.
Australian Medical Association President, Dr Bill Glasson, said today that Kraft Asia Pacific has missed a golden opportunity to show leadership in the battle against the epidemic of childhood obesity by not following its US counterpart and modifying advertising of its products to children under the age of 12.
› Verified 9 days ago
Ellen A Ronnen, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816 Phone: 732-390-7750 Fax: 732-390-7725 | |
Dr. Alan Sheldon Lichtbroun, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 63 Brunswick Woods Dr, East Brunswick, NJ 08816 Phone: 732-613-1900 Fax: 732-613-0029 | |
Dr. Francis C D'mello, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 385 State Route 18, West Ferris Plaza Unit K, East Brunswick, NJ 08816 Phone: 732-238-4343 Fax: 732-238-6981 | |
Dr. Jose C Costa, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 465 Cranbury Rd, Suite 102, East Brunswick, NJ 08816 Phone: 732-390-1995 Fax: 732-254-4610 | |
Dr. Mervat B Mansour, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Auer Ct Ste D, East Brunswick, NJ 08816 Phone: 732-257-5530 Fax: 732-257-5531 | |
Dr. Marsha Kallich, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 579a Cranbury Rd, Suite 102, East Brunswick, NJ 08816 Phone: 732-613-0711 Fax: 732-613-5783 | |
Raafat Ghobraiel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Brunswick Woods Dr, East Brunswick, NJ 08816 Phone: 732-254-7778 |